Karyopharm Therapeutics Inc. buy Piper Sandler
Start price
09.10.25
/
50%
€0.54
Target price
09.10.26
€10.31
Performance (%)
-
Price
-
-
Summary
This prediction has just been started. It does not have a price yet.. This prediction currently runs until 09.10.26. The prediction end date can be changed by Piper_Sandler at any time.Performance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Karyopharm Therapeutics Inc. | - | - |
| iShares Core DAX® | 0.734% | 1.458% |
| iShares Nasdaq 100 | -2.686% | -0.146% |
| iShares Nikkei 225® | -2.261% | -2.729% |
| iShares S&P 500 | -1.346% | 0.467% |
Comments by Piper_Sandler for this prediction
In the thread Karyopharm Therapeutics Inc. diskutieren
Karyopharm Therapeutics (NASDAQ:KPTI) had its "overweight" rating reaffirmed by analysts at Piper Sandler. They now have a $12.00 price target on the stock, down previously from $15.00.
Ratings data for KPTI provided by MarketBeat
Stopped prediction by Piper_Sandler for Karyopharm Therapeutics Inc.
Karyopharm Therapeutics Inc.
Start price
Target price
Perf. (%)
€0.83
06.11.24
06.11.24
€4.67
06.11.25
06.11.25
-33.98%
07.11.25
07.11.25
